Precision Biologic Inc
Main Filters
Precision Biologic Inc
| Precision Biologic Inc | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 00843876010113 | 0 | - | ||
| APCR-05 | 0 | - | ||
| ARP1-05 | 0 | - | ||
| ARP1-10 | 0 | - | ||
| ARP2-10 | 0 | - | ||
| CCA1-10 | 0 | - | ||
| CCC-15 | 0 | - | ||
| CCC-30 | 0 | - | ||
| CCCF08 | 0 | - | ||
| CCCF09 | 0 | - | ||
| CCIK08 | 0 | - | ||
| CCLF-10 | 0 | - | ||
| CCLN-05 | 0 | - | ||
| CCLN-10 | 0 | - | ||
| CCLP-05 | 0 | - | ||
| CCLP-10 | 0 | - | ||
| CCNRP-05 | 0 | - | ||
| CCNRP-10 | 0 | - | ||
| CCS-15 | 0 | - | ||
| CCS-30 | 0 | - | ||
| CCWLP-05 | 0 | - | ||
| CCWLP-10 | 0 | - | ||
| CHK-10 | 0 | - | ||
| CHK-40 | 0 | - | ||
| CHK50-30 | 0 | - | ||
| CHK80-10 | 0 | - | ||
| CSD | 0 | - | ||
| FDP02-10 | 0 | - | ||
| FDP02-15 | 0 | - | ||
| FDP05-10 | 0 | - | ||
| FDP05-15 | 0 | - | ||
| FDP07-10 | 0 | - | ||
| FDP07-15 | 0 | - | ||
| FDP08-10 | 0 | - | ||
| FDP08-15 | 0 | - | ||
| FDP08-40 | 0 | - | ||
| FDP09-10 | 0 | - | ||
| FDP09-15 | 0 | - | ||
| FDP10-10 | 0 | - | ||
| FDP10-15 | 0 | - | ||
| FDP11-10 | 0 | - | ||
| FDP11-15 | 0 | - | ||
| FDP12-10 | 0 | - | ||
| FDP12-15 | 0 | - | ||
| FDPK-10 | 0 | - | ||
| Hex LA | 0 | - | ||
| HEXLA-7 | 0 | - | ||
| PNP-10 | 0 | - | ||
| RCN-10 | 0 | - | ||
| SUR-10 | 0 | - | ||
55 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
CRYOcheck Chromogenic Factor IX
Precision Biologic Inc
CRYOcheck Chromogenic Factor IX is for clinical laboratory use in the quantitative determination of factor IX activity in 3.2% citrated human plasma. It is intended to be used in identifying factor IX deficiency and as an aid in the management of hemophilia B in individuals aged 2 years and older. For in vitro diagnostic use
0
-
CRYOcheck Factor VIII Chromogenic
Precision Biologic Inc
CRYOcheck Chromogenic Factor VIII is for clinical laboratory use in the quantitative determination of factor VIII activity in 3.2% citrated human plasma. It is intended to be used in identifying factor VIII deficiency and as an aid in the management of hemophilia A in individuals aged 2 years and older. For in vitro diagnostic use
0
-
CRYOcheck Lupus Negative Control
Precision Biologic Inc
Prepared from human source plasma and recommended as a negative control in assays for lupus anticoagulant.
0
-
CRYOcheck Lupus Negative Control
Precision Biologic Inc
Prepared from human source plasma and recommended as a negative control in assays for lupus anticoagulant.
0
-
CRYOcheck Hex LA
Precision Biologic Inc
CRYOcheck Hex LA is for clinical laboratory use as a qualitative test kit intended to aid in the detection of lupus anticoagulants (LA) in 3.2% citrated human plasma by the application of hexagonal phase phospholipids. CRYOcheck Hex LA should be used as an integrated test for lupus anticoagulant detection. For in vitro diagnostic use. The performance of this device has not been established in neonate and pediatric patient populations.
0
-
CRYOcheck Hex LA
Precision Biologic Inc
CRYOcheck Hex LA is for clinical laboratory use as a qualitative test kit intended to aid in the detection of lupus anticoagulants (LA) in 3.2% citrated human plasma by the application of hexagonal phase phospholipids. CRYOcheck Hex LA should be used as an integrated test for lupus anticoagulant detection. For in vitro diagnostic use. The performance of this device has not been established in neonate and pediatric patient populations.
0
-
CRYOcheck™ FVIII Inhibitor Kit
Precision Biologic Inc
The CRYOcheck FVIII Inhibitor Kit is for clinical laboratory use in conjunction with a factor VIII activity assay to enable performance of a modified Nijmegen-Bethesda assay using 3.2% citrated human plasma. It enables the determination of a functional FVIII inhibitor titer to aid in the clinical management of congenital hemophilia A in individuals aged 2 years and older.
- 1
- 2